The global veterinary intramuscular (IM) injection market is witnessing unprecedented growth, driven by the increasing demand for high-quality animal protein and the rising awareness of livestock health management. As an essential route for drug administration, IM injections ensure rapid absorption and high bioavailability, making them the gold standard for treating acute infections, metabolic disorders, and reproductive management in livestock and companion animals.
International pharmaceutical buyers are shifting focus towards long-acting formulations and highly stable synthetic chemical drugs. The integration of biotechnology with traditional pharmacology has led to more effective treatments for respiratory and gastrointestinal diseases in cattle, swine, and poultry. Current trends indicate a 6.5% CAGR in the veterinary injection market, with the Asia-Pacific and Latin American regions leading the procurement volume.
China has emerged as the global hub for Active Pharmaceutical Ingredients (API) and finished veterinary formulations. Our facilities in Hangzhou leverage China's robust chemical supply chain to provide premium-grade injections at competitive prices. By choosing a Chinese manufacturer like Hangzhou Jeci Biochem Technology Co., Ltd., global distributors benefit from:
Every region has unique challenges, from the high-temperature environments in Southeast Asia to the intensive dairy farming in Eastern Europe. Understanding local application scenarios is where we excel. For instance, our Cloprostenol Sodium injections are specifically formulated to synchronize estrus in varying climates, ensuring high success rates for livestock breeders worldwide.
We provide full-process support including product registration dossiers (CTD format), stability testing reports, and marketing materials. Our deep understanding of the regulatory landscapes in India, Korea, and Southeast Asia makes us more than just a supplier—we are a strategic partner in your market expansion.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
SJ medical
